Table of Content - Urinary Tract Infection (UTI) Treatment Market Expected to Grow at 3.2% by 2032

Urinary Tract Infection (UTI) Treatment Market By Drug Type (Penicillin, Quinolones, Cephalosporin, Sulphonamides, Tetracycline, Other) - Growth, Future Prospects, and Competitive Analysis, 2024 - 2032

11 Oct 2017 Format

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Urinary Tract Infection (UTI) Treatment Market
2.2. Global Urinary Tract Infection (UTI) Treatment Market, By Drug Class, 2023 (US$ Million)
2.3. Global Urinary Tract Infection (UTI) Treatment Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Urinary Tract Infection (UTI) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Urinary Tract Infection (UTI) Treatment Market Vendors
3.2. Strategies Adopted by Urinary Tract Infection (UTI) Treatment Market Vendors
3.3. Key Industry Strategies
4. Urinary Tract Infection (UTI) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Urinary Tract Infection (UTI) Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Penicillin
5.3.2. Quinolones
5.3.3. Cephalosporin
5.3.4. Sulphonamides
5.3.5. Tetracycline
5.3.6. Other

6. North America Urinary Tract Infection (UTI) Treatment Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
6.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)

7. UK and European Union Urinary Tract Infection (UTI) Treatment Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
7.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)

8. Asia Pacific Urinary Tract Infection (UTI) Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)

9. Latin America Urinary Tract Infection (UTI) Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)

10. Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2022-2032, USD (Million)

11. Company Profile
11.1. AstraZeneca plc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Bayer AG
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Cubist Pharmaceuticals
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. F. Hoffmann–La Roche Ltd.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. GlaxoSmithKline Pharmaceuticals Ltd.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Johnson & Johnson
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. MerLion Pharmaceuticals
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Osel Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Pfizer Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Rempex Pharmaceuticals
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives